Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0000950170-24-084292

Options or other derivatives

  • PRESIDENT acquired 50,975 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Sullivan Eddie Joe PRESIDENT 2024-07-15 Grant or award · Stock Option (right to buy) +46,528 46,528 D
Sullivan Eddie Joe PRESIDENT 2024-07-15 Grant or award · Stock Option (right to buy) +4,447 4,447 D
Loading xslF345X05/ownership.xml…